# TRAILRUNNER-ALZ 3

Source: https://onco.cc/trials/da-trial-trailrunner-alz3/  
OnCo record `da-trial-trailrunner-alz3` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

TRAILRUNNER-ALZ 3 is a Phase 3 programme for remternetug. Recruiting status changes; check ClinicalTrials.gov.

## Summary

An interventional amyloid-antibody study. Listing here is not a recommendation to enrol. Discuss eligibility only with a clinician and the study site.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-21
- Tags: dementia-atlas
- Registry id: NCT06653153
- Phase: 3
- Setting: Early Alzheimer’s disease
- Sponsor: Eli Lilly

## Sources

- ClinicalTrials.gov NCT06653153: https://clinicaltrials.gov/study/NCT06653153

## Connected records

- diagnoses: [Alzheimer’s disease](https://onco.cc/diagnoses/alzheimers-disease/)
- drugs: [Remternetug](https://onco.cc/drugs/da-remternetug/)
- companies: [Eli Lilly](https://onco.cc/companies/da-lilly/)

---
JSON: https://onco.cc/api/v1/entities/da-trial-trailrunner-alz3.json